PRostate Cancer Individual Signature Evaluation Trial in Patients Undergoing Scheduled Prostate Biopsy

Status unconfirmed

Conditions studied: Prostate Cancer

In brief

The purpose of this study is to develop and validate a blood-based diagnostic test that will predict prostate biopsy outcome as positive or negative for prostate cancer. Such a test will serve to reduce the number of unnecessary prostate biopsies.

Key facts

Study ID
NCT00966095
Run by
Source MDx
People needed
1200
Starts
2009-12-01
Last updated by the study team
2010-11-25

Who can join

Age: 40 and older. Sex: male. Healthy volunteers: not accepted.

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.